Biogen Inc. buy Royal Bank of Canada
Start price
14.02.24
/
50%
€210.80
Target price
14.02.25
€339.39
Performance (%)
-36.55%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. Massive losses of -36.55% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | -1.046% | -1.046% | -47.743% |
iShares Core DAX® | 0.130% | 3.439% | 29.827% |
iShares Nasdaq 100 | -0.443% | 4.555% | 8.195% |
iShares Nikkei 225® | 0.350% | 0.350% | -1.205% |
iShares S&P 500 | -0.203% | 3.724% | 6.183% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $364.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten